FIT Screening Cuts Colorectal Cancer Mortality by One Third (Medscape)

The study published in JAMA Network Open demonstrates that fecal immunochemical test (FIT) screening significantly reduces colorectal cancer (CRC) mortality by 33%, with a 42% reduction in deaths from left colon and rectal cancers. The research, conducted in two large, diverse U.S. health systems, highlights the effectiveness of FIT screening across various racial and ethnic groups. However, the benefits were not observed for right colon cancers. The study emphasizes the importance of coordinated, large-scale FIT screening efforts to prevent premature CRC deaths.